Clifford Chance

Clifford Chance advises Quintet Partners on acquisition of stake in diagnostic imaging business Exact Radiology

Leading international law firm Clifford Chance has advised Australian alternative asset manager Quintet Partners on its acquisition of a stake in diagnostic imaging business Exact Radiology. Quintent's investment is expected to help fund growth and support the group's expansion across industries and services.

The transaction was led by partner Mark Currell and counsel Jacob Kahwaji.

Mark said, "Financial sponsors are increasingly attracted to health care assets in Australia, and it has been a pleasure working with the Quintet team on what is their first investment in this sector."

Exact Radiology currently owns nine radiology clinics and provides services for a number of other locations in Queensland.

Jacob offers, "This transaction is reflective of the increasing pace of M&A in the Australian radiology sector over the past 12-18 months. We are delighted to have supported the Quintet team in bringing this transaction to fruition."

The firm has previously advised China Resources Pharmaceutical Group on its US$1.8 billion Hong Kong IPO, Moelis on a AUD$212 million digital healthcare IPO, a consortium led by CREAT Tiancheng Investment on a €940 million acquisition of German blood products business Biotest AG, CSL Limited on the US$352 million acquisition of a blood product manufacturer Ruide in China, and more recently Hansoh Pharmaceuticals on its US$1 billion IPO.